SlideShare une entreprise Scribd logo
1  sur  18
Télécharger pour lire hors ligne
BETTER
TOGETHER
Why pharma companies and
patient organizations need to
collaborate differently to deliver
better patient experiences.
A survey of 4,000 patients in
France, Germany, the UK and
the US.
Patient Inspired. Outcomes Driven.
Copyright © 2019 Accenture. All rights reserved.
CONDITION RESULTS
2
ABOUTTHE
RESEARCH
Online survey of 4,000 patients across 4
countries and 3 disease states to understand
how patients use and value services from patient
organizations compared to those of pharma
companies and whether integration of those
services would improve the patient experience.
THREEDISEASESTATES
Rheumatoid
Arthritis
Migraine Leukemia N=1000 N=1000 N=1000 N=1000
Copyright © 2019 Accenture. All rights reserved.
3
Who patients prefer to use services from
among pharma companies, healthcare
professionals, pharmacies, payers and
patient organizations for six key areas.
The degree to which patients use
and value services from patient
organization, and why they use
services from patient organizations.
Their level of engagement with patient
organizations now and in the future in
comparison to other healthcare players.
Which patient organizations
are most prominent and why.
If and how the patient experience could
improve with better coordination between
pharma and patient organizations.
WHATWESOUGHTTOUNDERSTAND
PREFERENCE
PROMINENCE
VALUE
ENGAGEMENT
IMPROVEMENT
Copyright © 2019 Accenture. All rights reserved.
4
• They engage early (pre-treatment)
and often with patient organizations
and intend to increase their
engagement with them over the
next two years—more so than they
intend to do so with pharma.
• The vast majority of patients believe
that pharma companies should be
working with patient organizations
to create a more seamless patient
experience.
• Patients highly value services
from patient organizations – and
use them as the primary go-to
provider for emotional support
and patient communities/support.
• Across the board, they prefer to
use services from patient
organizations over those from
pharmaceutical companies.
WHATDOPATIENTSTHINK
about services from patient organizations?
Copyright © 2019 Accenture. All rights reserved.
Patients prefer to use
services from patient
organizations.
Patients rank pharma the
lowest in understanding
them amongst healthcare
players.
Patient organizations
are winning in patient
engagement.
For all six services
questioned, including:
information on therapies
and clinical trials, managing
their condition, emotional
support, community and
patient support groups,
technology to support
them, and financial support.
47% of patients said pharma
companies understood their
emotional, financial and other
needs related to their
condition.
52% of patients are
already engaging more
with patient organizations
on a monthly basis
compared to pharma
companies (35%).
54% of patients said
they are going to engage
with patient organizations
more in the future vs. 35%
with pharma companies.
58% felt that patient
organizations understood
their needs.Over half of patients have
greater trust in and better
experiences with patient
organizations, finding it
easy to engage with them.
KEYFINDINGSSUMMARY
5Copyright © 2019 Accenture. All rights reserved.
6
On a scale of 1-5, how satisfied are you OVERALL with the level of emotional, financial, and other daily support
you get to manage your condition across all the organization's you engage with?
Satisfaction is high across the board for
services from patient organizations
Base: Total Respondents (4000); Migraine (1115); Rheumatoid Arthritis (1704); CLL (1181)
67% ofCLL patientsaresatisfiedoverallwiththelevel ofsupporttheygetto managetheir
conditionacrossallorganizationstheyengagewith.Only57% ofmigrainepatientsaresatisfied
withthelevelofemotional,financial,andotherdailysupporttheygetto managetheircondition.
KEY FINDING #1
Copyright © 2019 Accenture. All rights reserved.
7
On a scale of 1-5, how satisfied are you OVERALL with the level of emotional, financial, and other daily support
you get to manage your condition across all the organization's you engage with?
Satisfaction is high across the board for
services from patient organizations
Of all patients surveyed, 61% are completely or very satisfied with the services they receive from
patient organizations. 67% of CLLpatients are satisfiedoverallwith the levelof supportthey getto
manage their conditionacross all organizations they engagewith. Only 57% of migrainepatients are
satisfiedwith the level of emotional, financial,and other daily supportthey get to manage their condition.
KEY FINDING #1
Base: Total Respondents (4000); Migraine (1115); Rheumatoid Arthritis (1704); CLL (1181)Copyright © 2019 Accenture. All rights reserved.
8
How willing would you be to share detailed information about the daily impact of your condition with each of the
following organizations, if it helped you receive better care?
Patientsarewillingtosharetheirdatatogetbettercare.
Migraine patients were most willing to share information about the impact of their
condition with pharma companies (53%) but CLL patients were the least willing (44%).
KEY FINDING #1
Base: Total Respondents (4000); Migraine (1115); Rheumatoid Arthritis (1704); CLL (1181)Copyright © 2019 Accenture. All rights reserved.
9
Pharmaceutical companies ranked lowest in all three disease states (49% in Migraine, 47% in Arthritis,
and 44% in CLL).
Patients say that pharma doesn’t
understand their needs.
Less than half of patients (47%) said pharma companies understood their emotional,
financial and other needs related to their condition—again coming in last compared
to the other players.
KEY FINDING #2
Base: Total Respondents (4000); Migraine (1115); Rheumatoid Arthritis (1704); CLL (1181)Copyright © 2019 Accenture. All rights reserved.
10
Only 6% of CLL patients in the
US say they will increase their
engagement with pharma
companies. How do you think
your engagement with the
following organizations will
change over the next 2 years?
54% of patients said they are going to engage
with patient organizations more in the future.
Compared to 35% for pharma companies.
KEY FINDING #3
Base: Total Respondents (4000); Migraine (1115); Rheumatoid Arthritis (1704); CLL (1181)Copyright © 2019 Accenture. All rights reserved.
11
Only 6% of CLL patients in the
US say they will increase their
engagement with pharma
companies. How do you think
your engagement with the
following organizations will
change over the next 2 years?
54% of patients said they are going to engage
with patient organizations more in the future.
Compared to 35% for pharma companies.
KEY FINDING #3
Base: Total Respondents (4000); Migraine (1115); Rheumatoid Arthritis (1704); CLL (1181)Copyright © 2019 Accenture. All rights reserved.
12
How do you engage with the services offered by a patient organization?
The new facetime.
While patients are engaging the most with patient organizations by digital means
(online + email), over half of patients are attending events hosted by patient
organizations and calling to talk to a representative over 70% of the time.
KEY FINDING #3
Base: Total Respondents (4000); Migraine (1115); Rheumatoid Arthritis (1704); CLL (1181)Copyright © 2019 Accenture. All rights reserved.
13
Gain a better understanding
of patient needs—earlier
and more often.
of patients said pharma
companies would better
understand my needs…
By collaborating with patient organizations, pharma can:
of all patients use
services from patient
organizations before
treatment begins.
Provide a more seamless
patient experience.
of patients believe
pharma companies
should be working with
patient organizations…
of patients said pharma
companies would better
understand my needs.
Find new value
for patients.
How can partnering with
patient organization
create the potential to
build entirely new patient
experiences?
<1/3
50%
84%
61%
SOWHATDOESTHISMEAN
FORPHARMA?
Copyright © 2019 Accenture. All rights reserved.
14
29%
28%
25%
20%
22%
12%
39%
32%
28%
22%
18%
15%
TOP3PATIENTORGANIZATIONS:US
Chronic Migraine Patients CLL Patients Rheumatoid Arthritis Patients
American
Migraine
Foundation
(AMF)
Migraine
Support
(Facebook
Site)
Migraine
Research
Foundation
Association of
Cancer Online
Resources
(ACOR)
Association of
Community
Cancer Centers
(ACCC)
American Society
of Clinical
Oncology (ASCO)
Arthritis
Foundation
Rheumatoid
Arthritis
Support Group
(Facebook Site)
Rheumatoid
Arthritis Support
Network
Engaged with
over the past 2
years
Interacted
with the most
34%
30%
29%
16%
14%
13%
Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000)Copyright © 2019 Accenture. All rights reserved.
15
36%
33%
25%
19%
23%
15%
60%
42%
24%
43%
31%
12%
TOP3PATIENTORGANIZATIONS:UK
Chronic Migraine Patients CLL Patients Rheumatoid Arthritis Patients
The Migraine
Trust, U.K.
Leukaemia
CARE (includes
lymphoma)
Arthritis Care
Migraine Action
Association
(MAA)
Macmillan
Cancer Support
CLL Support
Association
(CLLSA)
National
Rheumatoid
Arthritis Society
Arthritis Action
Engaged with
over the past 2
years
Interacted
with the most
74%
40%
63%
27%
Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000)Copyright © 2019 Accenture. All rights reserved.
16
53%
33%
33%
40%
25%
23%
38%
26%
26%
23%
15%
14%
48%
43%
33%
36%
30%
22%
TOP3PATIENTORGANIZATIONS:FRANCE
Chronic Migraine Patients CLL Patients Rheumatoid Arthritis Patients
Association
France
Migraine
L’Association de
Soutien et
d’Information à la
Leucémie Lymphoïde
Chronique et la maladie
de Waldenström (SILLC)
Association
Française des
Polyarthritiques et
des rhumatismes
inflammatoires
chroniques (AFPric)
Club Migraine
et Céphalées
Société
Française
d'Etudes des
Migraines et
Céphalées
Association
Laurette Fugain
France federation
Leucemie espoir
Association Française
de Lutte Anti-
Rhumatismale
(A.F.L.A.R.)
Association Nationale
de Défense contre l'
Arthrite Rhumatoïde
(ANDAR)
Engaged with
over the past 2
years
Interacted
with the most
Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000)Copyright © 2019 Accenture. All rights reserved.
17
66%
39%
57%
28%
44%
37%
27%
29%
27%
18%
57%
53%
46%
47%
TOP3PATIENTORGANIZATIONS:GERMANY
Chronic Migraine Patients CLL Patients Rheumatoid Arthritis Patients
Die Deutsche
Migräne- und
Kopfschmerzg
esellschaft e.V.
(DMKG)
Deutsche
Leukämie- und
Lymphomhilfe
e.V.
Deutsche
Rheuma-Liga
Bundesverband
e.V.
MigräneLiga
Deutsche
Deutsche
Krebshilfe
Deutsche
Gesellschaft für
Rheumatologie
(DGRh) Engaged with
over the past 2
years
Interacted
with the most
Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000)Copyright © 2019 Accenture. All rights reserved.
18
CONTACT US
linkedin.com/company/
accenture_life_sciences
@AccentureLifeSci
www.accenture.com
/lifesciencesblog
Keena Patel
Accenture Life Sciences,
Managing Director,
Intelligent Patient Services
keena.b.patel@accenture.com
Eva Wiedenhöeft
Accenture Life Sciences,
Managing Director, European
Lead—Intelligent Patient Services
eva.wiedenhoeft@accenture.com
Copyright © 2019 Accenture. All rights reserved.
Accenture and its logo are trademarks of Accenture.
FOR MORE INFORMATION,
PLEASE VISIT:
www.accenture.com/patientservicessurvey

Contenu connexe

Tendances

2016 Healthcare Trends
2016 Healthcare Trends2016 Healthcare Trends
2016 Healthcare TrendsGSW
 
Personal Health Management
Personal Health ManagementPersonal Health Management
Personal Health ManagementPwC
 
Global healthcare 2017 outlook
Global healthcare 2017 outlookGlobal healthcare 2017 outlook
Global healthcare 2017 outlookBloomberg LP
 
Thirteen common pitfalls in consumer health engagement final 04 11
Thirteen common pitfalls in consumer health engagement final 04 11Thirteen common pitfalls in consumer health engagement final 04 11
Thirteen common pitfalls in consumer health engagement final 04 11George Van Antwerp
 
The 2016 HealthMine Digital Health Report
The 2016 HealthMine Digital Health ReportThe 2016 HealthMine Digital Health Report
The 2016 HealthMine Digital Health ReportFrenchWeb.fr
 
Engaging the hard_to_engage_through_innovative_channels
Engaging the hard_to_engage_through_innovative_channelsEngaging the hard_to_engage_through_innovative_channels
Engaging the hard_to_engage_through_innovative_channelsGeorge Van Antwerp
 
Improving statin adherence through interactive voice technology & barrier bre...
Improving statin adherence through interactive voice technology & barrier bre...Improving statin adherence through interactive voice technology & barrier bre...
Improving statin adherence through interactive voice technology & barrier bre...George Van Antwerp
 
Psychmentation
PsychmentationPsychmentation
Psychmentationamylonakis
 
8 Types of Mobile Hospital Apps
8 Types of Mobile Hospital Apps8 Types of Mobile Hospital Apps
8 Types of Mobile Hospital AppsMerraineGroup
 
Prescription Medicines: Costs in Context
Prescription Medicines: Costs in Context Prescription Medicines: Costs in Context
Prescription Medicines: Costs in Context PhRMA
 
Pega Healthcare Report
Pega Healthcare ReportPega Healthcare Report
Pega Healthcare ReportPegasystems
 
Pega Consumer Report
Pega Consumer ReportPega Consumer Report
Pega Consumer ReportPegasystems
 
3 Digital Healthcare Trends That We Can Expect to See More of in 2017
3 Digital Healthcare Trends That We Can Expect to See More of in 20173 Digital Healthcare Trends That We Can Expect to See More of in 2017
3 Digital Healthcare Trends That We Can Expect to See More of in 2017Jeremy Barbera
 
Healthcare Price Transparency: Three Opportunities for Transformation
Healthcare Price Transparency: Three Opportunities for TransformationHealthcare Price Transparency: Three Opportunities for Transformation
Healthcare Price Transparency: Three Opportunities for TransformationHealth Catalyst
 
PBMI 2013 Presentation on Shift From FFS to Value
PBMI 2013 Presentation on Shift From FFS to ValuePBMI 2013 Presentation on Shift From FFS to Value
PBMI 2013 Presentation on Shift From FFS to ValueGeorge Van Antwerp
 
Business model approaches to survive and thrive ncpdp - final
Business model approaches to survive and thrive   ncpdp - finalBusiness model approaches to survive and thrive   ncpdp - final
Business model approaches to survive and thrive ncpdp - finalGeorge Van Antwerp
 
Survey Shows the Role of Technology in the Progress of Patient Safety
Survey Shows the Role of Technology in the Progress of Patient SafetySurvey Shows the Role of Technology in the Progress of Patient Safety
Survey Shows the Role of Technology in the Progress of Patient SafetyHealth Catalyst
 
Creating the digital patient home
Creating the digital patient homeCreating the digital patient home
Creating the digital patient homeGeorge Van Antwerp
 
Strategy and digital health
Strategy and digital healthStrategy and digital health
Strategy and digital healthShiv ognito
 

Tendances (20)

Summary of Top Ten Health Industry Issues
Summary of Top Ten Health Industry IssuesSummary of Top Ten Health Industry Issues
Summary of Top Ten Health Industry Issues
 
2016 Healthcare Trends
2016 Healthcare Trends2016 Healthcare Trends
2016 Healthcare Trends
 
Personal Health Management
Personal Health ManagementPersonal Health Management
Personal Health Management
 
Global healthcare 2017 outlook
Global healthcare 2017 outlookGlobal healthcare 2017 outlook
Global healthcare 2017 outlook
 
Thirteen common pitfalls in consumer health engagement final 04 11
Thirteen common pitfalls in consumer health engagement final 04 11Thirteen common pitfalls in consumer health engagement final 04 11
Thirteen common pitfalls in consumer health engagement final 04 11
 
The 2016 HealthMine Digital Health Report
The 2016 HealthMine Digital Health ReportThe 2016 HealthMine Digital Health Report
The 2016 HealthMine Digital Health Report
 
Engaging the hard_to_engage_through_innovative_channels
Engaging the hard_to_engage_through_innovative_channelsEngaging the hard_to_engage_through_innovative_channels
Engaging the hard_to_engage_through_innovative_channels
 
Improving statin adherence through interactive voice technology & barrier bre...
Improving statin adherence through interactive voice technology & barrier bre...Improving statin adherence through interactive voice technology & barrier bre...
Improving statin adherence through interactive voice technology & barrier bre...
 
Psychmentation
PsychmentationPsychmentation
Psychmentation
 
8 Types of Mobile Hospital Apps
8 Types of Mobile Hospital Apps8 Types of Mobile Hospital Apps
8 Types of Mobile Hospital Apps
 
Prescription Medicines: Costs in Context
Prescription Medicines: Costs in Context Prescription Medicines: Costs in Context
Prescription Medicines: Costs in Context
 
Pega Healthcare Report
Pega Healthcare ReportPega Healthcare Report
Pega Healthcare Report
 
Pega Consumer Report
Pega Consumer ReportPega Consumer Report
Pega Consumer Report
 
3 Digital Healthcare Trends That We Can Expect to See More of in 2017
3 Digital Healthcare Trends That We Can Expect to See More of in 20173 Digital Healthcare Trends That We Can Expect to See More of in 2017
3 Digital Healthcare Trends That We Can Expect to See More of in 2017
 
Healthcare Price Transparency: Three Opportunities for Transformation
Healthcare Price Transparency: Three Opportunities for TransformationHealthcare Price Transparency: Three Opportunities for Transformation
Healthcare Price Transparency: Three Opportunities for Transformation
 
PBMI 2013 Presentation on Shift From FFS to Value
PBMI 2013 Presentation on Shift From FFS to ValuePBMI 2013 Presentation on Shift From FFS to Value
PBMI 2013 Presentation on Shift From FFS to Value
 
Business model approaches to survive and thrive ncpdp - final
Business model approaches to survive and thrive   ncpdp - finalBusiness model approaches to survive and thrive   ncpdp - final
Business model approaches to survive and thrive ncpdp - final
 
Survey Shows the Role of Technology in the Progress of Patient Safety
Survey Shows the Role of Technology in the Progress of Patient SafetySurvey Shows the Role of Technology in the Progress of Patient Safety
Survey Shows the Role of Technology in the Progress of Patient Safety
 
Creating the digital patient home
Creating the digital patient homeCreating the digital patient home
Creating the digital patient home
 
Strategy and digital health
Strategy and digital healthStrategy and digital health
Strategy and digital health
 

Similaire à Better Together 2019 Patient Services Survey - Condition Results

Millennial Mindset - Collaborative Clinician [lo res spreads]
Millennial Mindset - Collaborative Clinician [lo res spreads]Millennial Mindset - Collaborative Clinician [lo res spreads]
Millennial Mindset - Collaborative Clinician [lo res spreads]Amanda Cote Loban
 
mHealth Israel_GEARING COMMUNICATIONS TO RAISE CAPITAL AND ATTRACT CUSTOMERS_...
mHealth Israel_GEARING COMMUNICATIONS TO RAISE CAPITAL AND ATTRACT CUSTOMERS_...mHealth Israel_GEARING COMMUNICATIONS TO RAISE CAPITAL AND ATTRACT CUSTOMERS_...
mHealth Israel_GEARING COMMUNICATIONS TO RAISE CAPITAL AND ATTRACT CUSTOMERS_...Levi Shapiro
 
From Patients to ePatients Driving a new paradigm for online clinical collabo...
From Patients to ePatients Driving a new paradigm for online clinical collabo...From Patients to ePatients Driving a new paradigm for online clinical collabo...
From Patients to ePatients Driving a new paradigm for online clinical collabo...ddbennett
 
Centro Healthcare Category
Centro Healthcare Category Centro Healthcare Category
Centro Healthcare Category Centro
 
LOYALTY_Rx___Solving_the_consumer_loyalty_crisis_in_healthcare_with_data
LOYALTY_Rx___Solving_the_consumer_loyalty_crisis_in_healthcare_with_dataLOYALTY_Rx___Solving_the_consumer_loyalty_crisis_in_healthcare_with_data
LOYALTY_Rx___Solving_the_consumer_loyalty_crisis_in_healthcare_with_dataBill Wachs
 
How do we see the healthcare's digital future and its impact on our lives?
How do we see the healthcare's digital future and its impact on our lives?How do we see the healthcare's digital future and its impact on our lives?
How do we see the healthcare's digital future and its impact on our lives?Jane Vita
 
Healthcare's Digital Future
Healthcare's Digital Future Healthcare's Digital Future
Healthcare's Digital Future mirkka länsisalo
 
Pharma Industry Trends in 2015
Pharma Industry Trends in 2015Pharma Industry Trends in 2015
Pharma Industry Trends in 2015Synygy
 
How to Remedy the Dangers of Prescription Fraud, Waste, and Abuse
How to Remedy the Dangers of Prescription Fraud, Waste, and AbuseHow to Remedy the Dangers of Prescription Fraud, Waste, and Abuse
How to Remedy the Dangers of Prescription Fraud, Waste, and AbuseElizabeth Dimit
 
Mental Health Medication Use in Washington
Mental Health Medication Use in WashingtonMental Health Medication Use in Washington
Mental Health Medication Use in WashingtonMHTP Webmastere
 
Direct-To-Consumer Advertising
Direct-To-Consumer AdvertisingDirect-To-Consumer Advertising
Direct-To-Consumer AdvertisingCrystal Nelson
 
Quintiles new healthreport_2011
Quintiles new healthreport_2011Quintiles new healthreport_2011
Quintiles new healthreport_2011Quintiles
 
10 healthcare marketing statistics that matter now
10 healthcare marketing statistics that matter now10 healthcare marketing statistics that matter now
10 healthcare marketing statistics that matter nowGSW
 
Annual healthcare-professional-communication-report-2016
Annual healthcare-professional-communication-report-2016Annual healthcare-professional-communication-report-2016
Annual healthcare-professional-communication-report-2016Alberto Barlassina
 
Voice assistants in healthcare delivering contactless patient experience
Voice assistants in healthcare delivering contactless patient experienceVoice assistants in healthcare delivering contactless patient experience
Voice assistants in healthcare delivering contactless patient experienceEnterprise Bot
 
Accenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copyAccenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copyJim Fisher
 
Accenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copyAccenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copyJim Fisher
 
Accenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copyAccenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copyJim Fisher
 

Similaire à Better Together 2019 Patient Services Survey - Condition Results (20)

Millennial Mindset - Collaborative Clinician [lo res spreads]
Millennial Mindset - Collaborative Clinician [lo res spreads]Millennial Mindset - Collaborative Clinician [lo res spreads]
Millennial Mindset - Collaborative Clinician [lo res spreads]
 
Patients Like Me
Patients Like MePatients Like Me
Patients Like Me
 
mHealth Israel_GEARING COMMUNICATIONS TO RAISE CAPITAL AND ATTRACT CUSTOMERS_...
mHealth Israel_GEARING COMMUNICATIONS TO RAISE CAPITAL AND ATTRACT CUSTOMERS_...mHealth Israel_GEARING COMMUNICATIONS TO RAISE CAPITAL AND ATTRACT CUSTOMERS_...
mHealth Israel_GEARING COMMUNICATIONS TO RAISE CAPITAL AND ATTRACT CUSTOMERS_...
 
From Patients to ePatients Driving a new paradigm for online clinical collabo...
From Patients to ePatients Driving a new paradigm for online clinical collabo...From Patients to ePatients Driving a new paradigm for online clinical collabo...
From Patients to ePatients Driving a new paradigm for online clinical collabo...
 
Centro Healthcare Category
Centro Healthcare Category Centro Healthcare Category
Centro Healthcare Category
 
LOYALTY_Rx___Solving_the_consumer_loyalty_crisis_in_healthcare_with_data
LOYALTY_Rx___Solving_the_consumer_loyalty_crisis_in_healthcare_with_dataLOYALTY_Rx___Solving_the_consumer_loyalty_crisis_in_healthcare_with_data
LOYALTY_Rx___Solving_the_consumer_loyalty_crisis_in_healthcare_with_data
 
How do we see the healthcare's digital future and its impact on our lives?
How do we see the healthcare's digital future and its impact on our lives?How do we see the healthcare's digital future and its impact on our lives?
How do we see the healthcare's digital future and its impact on our lives?
 
Healthcare's Digital Future
Healthcare's Digital Future Healthcare's Digital Future
Healthcare's Digital Future
 
Pharma Industry Trends in 2015
Pharma Industry Trends in 2015Pharma Industry Trends in 2015
Pharma Industry Trends in 2015
 
Digital health in Asia
Digital health in AsiaDigital health in Asia
Digital health in Asia
 
How to Remedy the Dangers of Prescription Fraud, Waste, and Abuse
How to Remedy the Dangers of Prescription Fraud, Waste, and AbuseHow to Remedy the Dangers of Prescription Fraud, Waste, and Abuse
How to Remedy the Dangers of Prescription Fraud, Waste, and Abuse
 
Mental Health Medication Use in Washington
Mental Health Medication Use in WashingtonMental Health Medication Use in Washington
Mental Health Medication Use in Washington
 
Direct-To-Consumer Advertising
Direct-To-Consumer AdvertisingDirect-To-Consumer Advertising
Direct-To-Consumer Advertising
 
Quintiles new healthreport_2011
Quintiles new healthreport_2011Quintiles new healthreport_2011
Quintiles new healthreport_2011
 
10 healthcare marketing statistics that matter now
10 healthcare marketing statistics that matter now10 healthcare marketing statistics that matter now
10 healthcare marketing statistics that matter now
 
Annual healthcare-professional-communication-report-2016
Annual healthcare-professional-communication-report-2016Annual healthcare-professional-communication-report-2016
Annual healthcare-professional-communication-report-2016
 
Voice assistants in healthcare delivering contactless patient experience
Voice assistants in healthcare delivering contactless patient experienceVoice assistants in healthcare delivering contactless patient experience
Voice assistants in healthcare delivering contactless patient experience
 
Accenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copyAccenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copy
 
Accenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copyAccenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copy
 
Accenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copyAccenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copy
 

Plus de accenture

The Industrialist: Trends & Innovations - January 2024
The Industrialist: Trends & Innovations - January 2024The Industrialist: Trends & Innovations - January 2024
The Industrialist: Trends & Innovations - January 2024accenture
 
The Industrialist: Trends & Innovations - September 2023
The Industrialist: Trends & Innovations - September 2023The Industrialist: Trends & Innovations - September 2023
The Industrialist: Trends & Innovations - September 2023accenture
 
Accenture Technology Vision - How the trends apply to higher education
Accenture Technology Vision - How the trends apply to higher education Accenture Technology Vision - How the trends apply to higher education
Accenture Technology Vision - How the trends apply to higher education accenture
 
The Industrialist: Trends & Innovations - July 2023
The Industrialist: Trends & Innovations - July 2023The Industrialist: Trends & Innovations - July 2023
The Industrialist: Trends & Innovations - July 2023accenture
 
Accenture Technology Vision - How the trends apply to higher education
Accenture Technology Vision - How the trends apply to higher education Accenture Technology Vision - How the trends apply to higher education
Accenture Technology Vision - How the trends apply to higher education accenture
 
Engineering Services: con gli ingegneri per creare valore sostenibile
Engineering Services: con gli ingegneri per creare valore sostenibileEngineering Services: con gli ingegneri per creare valore sostenibile
Engineering Services: con gli ingegneri per creare valore sostenibileaccenture
 
Digital Euro: Implications for the Financial System
Digital Euro: Implications for the Financial SystemDigital Euro: Implications for the Financial System
Digital Euro: Implications for the Financial Systemaccenture
 
More deals, less money: the Black founder funding journey
More deals, less money: the Black founder funding journeyMore deals, less money: the Black founder funding journey
More deals, less money: the Black founder funding journeyaccenture
 
The Industrialist: Trends & Innovations - June 2023
The Industrialist: Trends & Innovations - June 2023The Industrialist: Trends & Innovations - June 2023
The Industrialist: Trends & Innovations - June 2023accenture
 
Reinventing Enterprise Operations
Reinventing Enterprise OperationsReinventing Enterprise Operations
Reinventing Enterprise Operationsaccenture
 
Semiconductor Gender Parity Study
Semiconductor Gender Parity StudySemiconductor Gender Parity Study
Semiconductor Gender Parity Studyaccenture
 
The Industrialist: Trends & Innovations - March 2023
The Industrialist: Trends & Innovations - March 2023The Industrialist: Trends & Innovations - March 2023
The Industrialist: Trends & Innovations - March 2023accenture
 
Nonprofit reinvention in a time of unprecedented change
 Nonprofit reinvention in a time of unprecedented change Nonprofit reinvention in a time of unprecedented change
Nonprofit reinvention in a time of unprecedented changeaccenture
 
Free to be 100% me
Free to be 100% meFree to be 100% me
Free to be 100% meaccenture
 
The Industrialist: Trends & Innovations - February 2023
The Industrialist: Trends & Innovations - February 2023The Industrialist: Trends & Innovations - February 2023
The Industrialist: Trends & Innovations - February 2023accenture
 
Mundo gamer e a oportunidade de entrada pela abordagem do movimento
Mundo gamer e a oportunidade de entrada pela abordagem do movimentoMundo gamer e a oportunidade de entrada pela abordagem do movimento
Mundo gamer e a oportunidade de entrada pela abordagem do movimentoaccenture
 
Pathways to Profitability for the Communications Industry
Pathways to Profitability for the Communications IndustryPathways to Profitability for the Communications Industry
Pathways to Profitability for the Communications Industryaccenture
 
The Industrialist: Trends & Innovations - January 2023
The Industrialist: Trends & Innovations - January 2023The Industrialist: Trends & Innovations - January 2023
The Industrialist: Trends & Innovations - January 2023accenture
 
Reimagining the Agenda | Accenture
Reimagining the Agenda | AccentureReimagining the Agenda | Accenture
Reimagining the Agenda | Accentureaccenture
 
Climate Leadership Eleventh Hour | Accenture
Climate Leadership Eleventh Hour | AccentureClimate Leadership Eleventh Hour | Accenture
Climate Leadership Eleventh Hour | Accentureaccenture
 

Plus de accenture (20)

The Industrialist: Trends & Innovations - January 2024
The Industrialist: Trends & Innovations - January 2024The Industrialist: Trends & Innovations - January 2024
The Industrialist: Trends & Innovations - January 2024
 
The Industrialist: Trends & Innovations - September 2023
The Industrialist: Trends & Innovations - September 2023The Industrialist: Trends & Innovations - September 2023
The Industrialist: Trends & Innovations - September 2023
 
Accenture Technology Vision - How the trends apply to higher education
Accenture Technology Vision - How the trends apply to higher education Accenture Technology Vision - How the trends apply to higher education
Accenture Technology Vision - How the trends apply to higher education
 
The Industrialist: Trends & Innovations - July 2023
The Industrialist: Trends & Innovations - July 2023The Industrialist: Trends & Innovations - July 2023
The Industrialist: Trends & Innovations - July 2023
 
Accenture Technology Vision - How the trends apply to higher education
Accenture Technology Vision - How the trends apply to higher education Accenture Technology Vision - How the trends apply to higher education
Accenture Technology Vision - How the trends apply to higher education
 
Engineering Services: con gli ingegneri per creare valore sostenibile
Engineering Services: con gli ingegneri per creare valore sostenibileEngineering Services: con gli ingegneri per creare valore sostenibile
Engineering Services: con gli ingegneri per creare valore sostenibile
 
Digital Euro: Implications for the Financial System
Digital Euro: Implications for the Financial SystemDigital Euro: Implications for the Financial System
Digital Euro: Implications for the Financial System
 
More deals, less money: the Black founder funding journey
More deals, less money: the Black founder funding journeyMore deals, less money: the Black founder funding journey
More deals, less money: the Black founder funding journey
 
The Industrialist: Trends & Innovations - June 2023
The Industrialist: Trends & Innovations - June 2023The Industrialist: Trends & Innovations - June 2023
The Industrialist: Trends & Innovations - June 2023
 
Reinventing Enterprise Operations
Reinventing Enterprise OperationsReinventing Enterprise Operations
Reinventing Enterprise Operations
 
Semiconductor Gender Parity Study
Semiconductor Gender Parity StudySemiconductor Gender Parity Study
Semiconductor Gender Parity Study
 
The Industrialist: Trends & Innovations - March 2023
The Industrialist: Trends & Innovations - March 2023The Industrialist: Trends & Innovations - March 2023
The Industrialist: Trends & Innovations - March 2023
 
Nonprofit reinvention in a time of unprecedented change
 Nonprofit reinvention in a time of unprecedented change Nonprofit reinvention in a time of unprecedented change
Nonprofit reinvention in a time of unprecedented change
 
Free to be 100% me
Free to be 100% meFree to be 100% me
Free to be 100% me
 
The Industrialist: Trends & Innovations - February 2023
The Industrialist: Trends & Innovations - February 2023The Industrialist: Trends & Innovations - February 2023
The Industrialist: Trends & Innovations - February 2023
 
Mundo gamer e a oportunidade de entrada pela abordagem do movimento
Mundo gamer e a oportunidade de entrada pela abordagem do movimentoMundo gamer e a oportunidade de entrada pela abordagem do movimento
Mundo gamer e a oportunidade de entrada pela abordagem do movimento
 
Pathways to Profitability for the Communications Industry
Pathways to Profitability for the Communications IndustryPathways to Profitability for the Communications Industry
Pathways to Profitability for the Communications Industry
 
The Industrialist: Trends & Innovations - January 2023
The Industrialist: Trends & Innovations - January 2023The Industrialist: Trends & Innovations - January 2023
The Industrialist: Trends & Innovations - January 2023
 
Reimagining the Agenda | Accenture
Reimagining the Agenda | AccentureReimagining the Agenda | Accenture
Reimagining the Agenda | Accenture
 
Climate Leadership Eleventh Hour | Accenture
Climate Leadership Eleventh Hour | AccentureClimate Leadership Eleventh Hour | Accenture
Climate Leadership Eleventh Hour | Accenture
 

Dernier

COMPUTER 10 Lesson 8 - Building a Website
COMPUTER 10 Lesson 8 - Building a WebsiteCOMPUTER 10 Lesson 8 - Building a Website
COMPUTER 10 Lesson 8 - Building a Websitedgelyza
 
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...Will Schroeder
 
GenAI and AI GCC State of AI_Object Automation Inc
GenAI and AI GCC State of AI_Object Automation IncGenAI and AI GCC State of AI_Object Automation Inc
GenAI and AI GCC State of AI_Object Automation IncObject Automation
 
20200723_insight_release_plan_v6.pdf20200723_insight_release_plan_v6.pdf
20200723_insight_release_plan_v6.pdf20200723_insight_release_plan_v6.pdf20200723_insight_release_plan_v6.pdf20200723_insight_release_plan_v6.pdf
20200723_insight_release_plan_v6.pdf20200723_insight_release_plan_v6.pdfJamie (Taka) Wang
 
UiPath Studio Web workshop series - Day 7
UiPath Studio Web workshop series - Day 7UiPath Studio Web workshop series - Day 7
UiPath Studio Web workshop series - Day 7DianaGray10
 
COMPUTER 10: Lesson 7 - File Storage and Online Collaboration
COMPUTER 10: Lesson 7 - File Storage and Online CollaborationCOMPUTER 10: Lesson 7 - File Storage and Online Collaboration
COMPUTER 10: Lesson 7 - File Storage and Online Collaborationbruanjhuli
 
Meet the new FSP 3000 M-Flex800™
Meet the new FSP 3000 M-Flex800™Meet the new FSP 3000 M-Flex800™
Meet the new FSP 3000 M-Flex800™Adtran
 
Salesforce Miami User Group Event - 1st Quarter 2024
Salesforce Miami User Group Event - 1st Quarter 2024Salesforce Miami User Group Event - 1st Quarter 2024
Salesforce Miami User Group Event - 1st Quarter 2024SkyPlanner
 
Computer 10: Lesson 10 - Online Crimes and Hazards
Computer 10: Lesson 10 - Online Crimes and HazardsComputer 10: Lesson 10 - Online Crimes and Hazards
Computer 10: Lesson 10 - Online Crimes and HazardsSeth Reyes
 
Comparing Sidecar-less Service Mesh from Cilium and Istio
Comparing Sidecar-less Service Mesh from Cilium and IstioComparing Sidecar-less Service Mesh from Cilium and Istio
Comparing Sidecar-less Service Mesh from Cilium and IstioChristian Posta
 
KubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCost
KubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCostKubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCost
KubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCostMatt Ray
 
UiPath Community: AI for UiPath Automation Developers
UiPath Community: AI for UiPath Automation DevelopersUiPath Community: AI for UiPath Automation Developers
UiPath Community: AI for UiPath Automation DevelopersUiPathCommunity
 
UiPath Platform: The Backend Engine Powering Your Automation - Session 1
UiPath Platform: The Backend Engine Powering Your Automation - Session 1UiPath Platform: The Backend Engine Powering Your Automation - Session 1
UiPath Platform: The Backend Engine Powering Your Automation - Session 1DianaGray10
 
Bird eye's view on Camunda open source ecosystem
Bird eye's view on Camunda open source ecosystemBird eye's view on Camunda open source ecosystem
Bird eye's view on Camunda open source ecosystemAsko Soukka
 
IaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdf
IaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdfIaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdf
IaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdfDaniel Santiago Silva Capera
 
How to Effectively Monitor SD-WAN and SASE Environments with ThousandEyes
How to Effectively Monitor SD-WAN and SASE Environments with ThousandEyesHow to Effectively Monitor SD-WAN and SASE Environments with ThousandEyes
How to Effectively Monitor SD-WAN and SASE Environments with ThousandEyesThousandEyes
 
Crea il tuo assistente AI con lo Stregatto (open source python framework)
Crea il tuo assistente AI con lo Stregatto (open source python framework)Crea il tuo assistente AI con lo Stregatto (open source python framework)
Crea il tuo assistente AI con lo Stregatto (open source python framework)Commit University
 
Introduction to Matsuo Laboratory (ENG).pptx
Introduction to Matsuo Laboratory (ENG).pptxIntroduction to Matsuo Laboratory (ENG).pptx
Introduction to Matsuo Laboratory (ENG).pptxMatsuo Lab
 
PicPay - GenAI Finance Assistant - ChatGPT for Customer Service
PicPay - GenAI Finance Assistant - ChatGPT for Customer ServicePicPay - GenAI Finance Assistant - ChatGPT for Customer Service
PicPay - GenAI Finance Assistant - ChatGPT for Customer ServiceRenan Moreira de Oliveira
 
Artificial Intelligence & SEO Trends for 2024
Artificial Intelligence & SEO Trends for 2024Artificial Intelligence & SEO Trends for 2024
Artificial Intelligence & SEO Trends for 2024D Cloud Solutions
 

Dernier (20)

COMPUTER 10 Lesson 8 - Building a Website
COMPUTER 10 Lesson 8 - Building a WebsiteCOMPUTER 10 Lesson 8 - Building a Website
COMPUTER 10 Lesson 8 - Building a Website
 
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
 
GenAI and AI GCC State of AI_Object Automation Inc
GenAI and AI GCC State of AI_Object Automation IncGenAI and AI GCC State of AI_Object Automation Inc
GenAI and AI GCC State of AI_Object Automation Inc
 
20200723_insight_release_plan_v6.pdf20200723_insight_release_plan_v6.pdf
20200723_insight_release_plan_v6.pdf20200723_insight_release_plan_v6.pdf20200723_insight_release_plan_v6.pdf20200723_insight_release_plan_v6.pdf
20200723_insight_release_plan_v6.pdf20200723_insight_release_plan_v6.pdf
 
UiPath Studio Web workshop series - Day 7
UiPath Studio Web workshop series - Day 7UiPath Studio Web workshop series - Day 7
UiPath Studio Web workshop series - Day 7
 
COMPUTER 10: Lesson 7 - File Storage and Online Collaboration
COMPUTER 10: Lesson 7 - File Storage and Online CollaborationCOMPUTER 10: Lesson 7 - File Storage and Online Collaboration
COMPUTER 10: Lesson 7 - File Storage and Online Collaboration
 
Meet the new FSP 3000 M-Flex800™
Meet the new FSP 3000 M-Flex800™Meet the new FSP 3000 M-Flex800™
Meet the new FSP 3000 M-Flex800™
 
Salesforce Miami User Group Event - 1st Quarter 2024
Salesforce Miami User Group Event - 1st Quarter 2024Salesforce Miami User Group Event - 1st Quarter 2024
Salesforce Miami User Group Event - 1st Quarter 2024
 
Computer 10: Lesson 10 - Online Crimes and Hazards
Computer 10: Lesson 10 - Online Crimes and HazardsComputer 10: Lesson 10 - Online Crimes and Hazards
Computer 10: Lesson 10 - Online Crimes and Hazards
 
Comparing Sidecar-less Service Mesh from Cilium and Istio
Comparing Sidecar-less Service Mesh from Cilium and IstioComparing Sidecar-less Service Mesh from Cilium and Istio
Comparing Sidecar-less Service Mesh from Cilium and Istio
 
KubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCost
KubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCostKubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCost
KubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCost
 
UiPath Community: AI for UiPath Automation Developers
UiPath Community: AI for UiPath Automation DevelopersUiPath Community: AI for UiPath Automation Developers
UiPath Community: AI for UiPath Automation Developers
 
UiPath Platform: The Backend Engine Powering Your Automation - Session 1
UiPath Platform: The Backend Engine Powering Your Automation - Session 1UiPath Platform: The Backend Engine Powering Your Automation - Session 1
UiPath Platform: The Backend Engine Powering Your Automation - Session 1
 
Bird eye's view on Camunda open source ecosystem
Bird eye's view on Camunda open source ecosystemBird eye's view on Camunda open source ecosystem
Bird eye's view on Camunda open source ecosystem
 
IaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdf
IaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdfIaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdf
IaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdf
 
How to Effectively Monitor SD-WAN and SASE Environments with ThousandEyes
How to Effectively Monitor SD-WAN and SASE Environments with ThousandEyesHow to Effectively Monitor SD-WAN and SASE Environments with ThousandEyes
How to Effectively Monitor SD-WAN and SASE Environments with ThousandEyes
 
Crea il tuo assistente AI con lo Stregatto (open source python framework)
Crea il tuo assistente AI con lo Stregatto (open source python framework)Crea il tuo assistente AI con lo Stregatto (open source python framework)
Crea il tuo assistente AI con lo Stregatto (open source python framework)
 
Introduction to Matsuo Laboratory (ENG).pptx
Introduction to Matsuo Laboratory (ENG).pptxIntroduction to Matsuo Laboratory (ENG).pptx
Introduction to Matsuo Laboratory (ENG).pptx
 
PicPay - GenAI Finance Assistant - ChatGPT for Customer Service
PicPay - GenAI Finance Assistant - ChatGPT for Customer ServicePicPay - GenAI Finance Assistant - ChatGPT for Customer Service
PicPay - GenAI Finance Assistant - ChatGPT for Customer Service
 
Artificial Intelligence & SEO Trends for 2024
Artificial Intelligence & SEO Trends for 2024Artificial Intelligence & SEO Trends for 2024
Artificial Intelligence & SEO Trends for 2024
 

Better Together 2019 Patient Services Survey - Condition Results

  • 1. BETTER TOGETHER Why pharma companies and patient organizations need to collaborate differently to deliver better patient experiences. A survey of 4,000 patients in France, Germany, the UK and the US. Patient Inspired. Outcomes Driven. Copyright © 2019 Accenture. All rights reserved. CONDITION RESULTS
  • 2. 2 ABOUTTHE RESEARCH Online survey of 4,000 patients across 4 countries and 3 disease states to understand how patients use and value services from patient organizations compared to those of pharma companies and whether integration of those services would improve the patient experience. THREEDISEASESTATES Rheumatoid Arthritis Migraine Leukemia N=1000 N=1000 N=1000 N=1000 Copyright © 2019 Accenture. All rights reserved.
  • 3. 3 Who patients prefer to use services from among pharma companies, healthcare professionals, pharmacies, payers and patient organizations for six key areas. The degree to which patients use and value services from patient organization, and why they use services from patient organizations. Their level of engagement with patient organizations now and in the future in comparison to other healthcare players. Which patient organizations are most prominent and why. If and how the patient experience could improve with better coordination between pharma and patient organizations. WHATWESOUGHTTOUNDERSTAND PREFERENCE PROMINENCE VALUE ENGAGEMENT IMPROVEMENT Copyright © 2019 Accenture. All rights reserved.
  • 4. 4 • They engage early (pre-treatment) and often with patient organizations and intend to increase their engagement with them over the next two years—more so than they intend to do so with pharma. • The vast majority of patients believe that pharma companies should be working with patient organizations to create a more seamless patient experience. • Patients highly value services from patient organizations – and use them as the primary go-to provider for emotional support and patient communities/support. • Across the board, they prefer to use services from patient organizations over those from pharmaceutical companies. WHATDOPATIENTSTHINK about services from patient organizations? Copyright © 2019 Accenture. All rights reserved.
  • 5. Patients prefer to use services from patient organizations. Patients rank pharma the lowest in understanding them amongst healthcare players. Patient organizations are winning in patient engagement. For all six services questioned, including: information on therapies and clinical trials, managing their condition, emotional support, community and patient support groups, technology to support them, and financial support. 47% of patients said pharma companies understood their emotional, financial and other needs related to their condition. 52% of patients are already engaging more with patient organizations on a monthly basis compared to pharma companies (35%). 54% of patients said they are going to engage with patient organizations more in the future vs. 35% with pharma companies. 58% felt that patient organizations understood their needs.Over half of patients have greater trust in and better experiences with patient organizations, finding it easy to engage with them. KEYFINDINGSSUMMARY 5Copyright © 2019 Accenture. All rights reserved.
  • 6. 6 On a scale of 1-5, how satisfied are you OVERALL with the level of emotional, financial, and other daily support you get to manage your condition across all the organization's you engage with? Satisfaction is high across the board for services from patient organizations Base: Total Respondents (4000); Migraine (1115); Rheumatoid Arthritis (1704); CLL (1181) 67% ofCLL patientsaresatisfiedoverallwiththelevel ofsupporttheygetto managetheir conditionacrossallorganizationstheyengagewith.Only57% ofmigrainepatientsaresatisfied withthelevelofemotional,financial,andotherdailysupporttheygetto managetheircondition. KEY FINDING #1 Copyright © 2019 Accenture. All rights reserved.
  • 7. 7 On a scale of 1-5, how satisfied are you OVERALL with the level of emotional, financial, and other daily support you get to manage your condition across all the organization's you engage with? Satisfaction is high across the board for services from patient organizations Of all patients surveyed, 61% are completely or very satisfied with the services they receive from patient organizations. 67% of CLLpatients are satisfiedoverallwith the levelof supportthey getto manage their conditionacross all organizations they engagewith. Only 57% of migrainepatients are satisfiedwith the level of emotional, financial,and other daily supportthey get to manage their condition. KEY FINDING #1 Base: Total Respondents (4000); Migraine (1115); Rheumatoid Arthritis (1704); CLL (1181)Copyright © 2019 Accenture. All rights reserved.
  • 8. 8 How willing would you be to share detailed information about the daily impact of your condition with each of the following organizations, if it helped you receive better care? Patientsarewillingtosharetheirdatatogetbettercare. Migraine patients were most willing to share information about the impact of their condition with pharma companies (53%) but CLL patients were the least willing (44%). KEY FINDING #1 Base: Total Respondents (4000); Migraine (1115); Rheumatoid Arthritis (1704); CLL (1181)Copyright © 2019 Accenture. All rights reserved.
  • 9. 9 Pharmaceutical companies ranked lowest in all three disease states (49% in Migraine, 47% in Arthritis, and 44% in CLL). Patients say that pharma doesn’t understand their needs. Less than half of patients (47%) said pharma companies understood their emotional, financial and other needs related to their condition—again coming in last compared to the other players. KEY FINDING #2 Base: Total Respondents (4000); Migraine (1115); Rheumatoid Arthritis (1704); CLL (1181)Copyright © 2019 Accenture. All rights reserved.
  • 10. 10 Only 6% of CLL patients in the US say they will increase their engagement with pharma companies. How do you think your engagement with the following organizations will change over the next 2 years? 54% of patients said they are going to engage with patient organizations more in the future. Compared to 35% for pharma companies. KEY FINDING #3 Base: Total Respondents (4000); Migraine (1115); Rheumatoid Arthritis (1704); CLL (1181)Copyright © 2019 Accenture. All rights reserved.
  • 11. 11 Only 6% of CLL patients in the US say they will increase their engagement with pharma companies. How do you think your engagement with the following organizations will change over the next 2 years? 54% of patients said they are going to engage with patient organizations more in the future. Compared to 35% for pharma companies. KEY FINDING #3 Base: Total Respondents (4000); Migraine (1115); Rheumatoid Arthritis (1704); CLL (1181)Copyright © 2019 Accenture. All rights reserved.
  • 12. 12 How do you engage with the services offered by a patient organization? The new facetime. While patients are engaging the most with patient organizations by digital means (online + email), over half of patients are attending events hosted by patient organizations and calling to talk to a representative over 70% of the time. KEY FINDING #3 Base: Total Respondents (4000); Migraine (1115); Rheumatoid Arthritis (1704); CLL (1181)Copyright © 2019 Accenture. All rights reserved.
  • 13. 13 Gain a better understanding of patient needs—earlier and more often. of patients said pharma companies would better understand my needs… By collaborating with patient organizations, pharma can: of all patients use services from patient organizations before treatment begins. Provide a more seamless patient experience. of patients believe pharma companies should be working with patient organizations… of patients said pharma companies would better understand my needs. Find new value for patients. How can partnering with patient organization create the potential to build entirely new patient experiences? <1/3 50% 84% 61% SOWHATDOESTHISMEAN FORPHARMA? Copyright © 2019 Accenture. All rights reserved.
  • 14. 14 29% 28% 25% 20% 22% 12% 39% 32% 28% 22% 18% 15% TOP3PATIENTORGANIZATIONS:US Chronic Migraine Patients CLL Patients Rheumatoid Arthritis Patients American Migraine Foundation (AMF) Migraine Support (Facebook Site) Migraine Research Foundation Association of Cancer Online Resources (ACOR) Association of Community Cancer Centers (ACCC) American Society of Clinical Oncology (ASCO) Arthritis Foundation Rheumatoid Arthritis Support Group (Facebook Site) Rheumatoid Arthritis Support Network Engaged with over the past 2 years Interacted with the most 34% 30% 29% 16% 14% 13% Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000)Copyright © 2019 Accenture. All rights reserved.
  • 15. 15 36% 33% 25% 19% 23% 15% 60% 42% 24% 43% 31% 12% TOP3PATIENTORGANIZATIONS:UK Chronic Migraine Patients CLL Patients Rheumatoid Arthritis Patients The Migraine Trust, U.K. Leukaemia CARE (includes lymphoma) Arthritis Care Migraine Action Association (MAA) Macmillan Cancer Support CLL Support Association (CLLSA) National Rheumatoid Arthritis Society Arthritis Action Engaged with over the past 2 years Interacted with the most 74% 40% 63% 27% Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000)Copyright © 2019 Accenture. All rights reserved.
  • 16. 16 53% 33% 33% 40% 25% 23% 38% 26% 26% 23% 15% 14% 48% 43% 33% 36% 30% 22% TOP3PATIENTORGANIZATIONS:FRANCE Chronic Migraine Patients CLL Patients Rheumatoid Arthritis Patients Association France Migraine L’Association de Soutien et d’Information à la Leucémie Lymphoïde Chronique et la maladie de Waldenström (SILLC) Association Française des Polyarthritiques et des rhumatismes inflammatoires chroniques (AFPric) Club Migraine et Céphalées Société Française d'Etudes des Migraines et Céphalées Association Laurette Fugain France federation Leucemie espoir Association Française de Lutte Anti- Rhumatismale (A.F.L.A.R.) Association Nationale de Défense contre l' Arthrite Rhumatoïde (ANDAR) Engaged with over the past 2 years Interacted with the most Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000)Copyright © 2019 Accenture. All rights reserved.
  • 17. 17 66% 39% 57% 28% 44% 37% 27% 29% 27% 18% 57% 53% 46% 47% TOP3PATIENTORGANIZATIONS:GERMANY Chronic Migraine Patients CLL Patients Rheumatoid Arthritis Patients Die Deutsche Migräne- und Kopfschmerzg esellschaft e.V. (DMKG) Deutsche Leukämie- und Lymphomhilfe e.V. Deutsche Rheuma-Liga Bundesverband e.V. MigräneLiga Deutsche Deutsche Krebshilfe Deutsche Gesellschaft für Rheumatologie (DGRh) Engaged with over the past 2 years Interacted with the most Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000)Copyright © 2019 Accenture. All rights reserved.
  • 18. 18 CONTACT US linkedin.com/company/ accenture_life_sciences @AccentureLifeSci www.accenture.com /lifesciencesblog Keena Patel Accenture Life Sciences, Managing Director, Intelligent Patient Services keena.b.patel@accenture.com Eva Wiedenhöeft Accenture Life Sciences, Managing Director, European Lead—Intelligent Patient Services eva.wiedenhoeft@accenture.com Copyright © 2019 Accenture. All rights reserved. Accenture and its logo are trademarks of Accenture. FOR MORE INFORMATION, PLEASE VISIT: www.accenture.com/patientservicessurvey